Immunology. Therapeutic manipulation of gut flora

Typeset version

 

TY  - JOUR
  - Shanahan, F.
  - 2000
  - August
  - Sciencescience
  - Immunology. Therapeutic manipulation of gut flora
  - Validated
  - ()
  - 289
  - 54835483
  - 1311
  - 2
  - In developed countries as many as two individuals in every thousand suffer from inflammatory bowel disease (ulcerative colitis and Crohn's disease). In his Perspective, Shanahan discusses a new therapeutic approach to treating these conditions in which bacteria normally found in the gut are engineered to produce the anti-inflammatory cytokine interleukin-10 and then are fed as probiotics to mice with these disorders (Steidler et al.).In developed countries as many as two individuals in every thousand suffer from inflammatory bowel disease (ulcerative colitis and Crohn's disease). In his Perspective, Shanahan discusses a new therapeutic approach to treating these conditions in which bacteria normally found in the gut are engineered to produce the anti-inflammatory cytokine interleukin-10 and then are fed as probiotics to mice with these disorders (Steidler et al.).
  - 0036-8075 (Print) 0036-80
DA  - 2000/08
ER  - 
@article{V280546910,
   = {Shanahan,  F. },
   = {2000},
   = {August},
   = {Sciencescience},
   = {Immunology. Therapeutic manipulation of gut flora},
   = {Validated},
   = {()},
   = {289},
   = {54835483},
  pages = {1311--2},
   = {{In developed countries as many as two individuals in every thousand suffer from inflammatory bowel disease (ulcerative colitis and Crohn's disease). In his Perspective, Shanahan discusses a new therapeutic approach to treating these conditions in which bacteria normally found in the gut are engineered to produce the anti-inflammatory cytokine interleukin-10 and then are fed as probiotics to mice with these disorders (Steidler et al.).In developed countries as many as two individuals in every thousand suffer from inflammatory bowel disease (ulcerative colitis and Crohn's disease). In his Perspective, Shanahan discusses a new therapeutic approach to treating these conditions in which bacteria normally found in the gut are engineered to produce the anti-inflammatory cytokine interleukin-10 and then are fed as probiotics to mice with these disorders (Steidler et al.).}},
  issn = {0036-8075 (Print) 0036-80},
  source = {IRIS}
}
AUTHORSShanahan, F.
YEAR2000
MONTHAugust
JOURNAL_CODESciencescience
TITLEImmunology. Therapeutic manipulation of gut flora
STATUSValidated
TIMES_CITED()
SEARCH_KEYWORD
VOLUME289
ISSUE54835483
START_PAGE1311
END_PAGE2
ABSTRACTIn developed countries as many as two individuals in every thousand suffer from inflammatory bowel disease (ulcerative colitis and Crohn's disease). In his Perspective, Shanahan discusses a new therapeutic approach to treating these conditions in which bacteria normally found in the gut are engineered to produce the anti-inflammatory cytokine interleukin-10 and then are fed as probiotics to mice with these disorders (Steidler et al.).In developed countries as many as two individuals in every thousand suffer from inflammatory bowel disease (ulcerative colitis and Crohn's disease). In his Perspective, Shanahan discusses a new therapeutic approach to treating these conditions in which bacteria normally found in the gut are engineered to produce the anti-inflammatory cytokine interleukin-10 and then are fed as probiotics to mice with these disorders (Steidler et al.).
PUBLISHER_LOCATION
ISBN_ISSN0036-8075 (Print) 0036-80
EDITION
URL
DOI_LINK
FUNDING_BODY
GRANT_DETAILS